![]() |
市場調査レポート
商品コード
1309867
全ゲノムシーケンス市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028. Segmented By Sequencing Type, By Product Type, By Application, By End User, By Region and Competition |
||||||
カスタマイズ可能
|
全ゲノムシーケンス市場- 世界の産業規模、シェア、動向、競合、機会、予測、2018-2028年 |
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 115 Pages
納期: 2~3営業日
|
全ゲノムシーケンス市場は、予測期間2024-2028年に目覚ましいCAGRで成長すると予想されます。
これは、以下のような要因によるものと考えられます。
NGS装置における技術進歩の増加とシーケンス技術で利用される技術の更新は、予測期間においてシーケンス市場の成長をさらに促進する要因となっています。さらに、次世代シーケンシング(NGS)は、その多重化機能により、キャピラリーシーケンシングやPCRベースの方法とは異なり、微生物研究者が数百の生物の配列を決定することを可能にします。NGSベースの微生物ゲノムシーケンスは時間効率が高く、ワークフローを合理化し、旧来の技術のように時間のかかるクローニング段階に依存しません。さらに、見落とされる可能性のある低頻度の変異やゲノムの再配列は、現在の技術では高価すぎて見つけることができませんが、NGS(次世代シーケンサー)を使えば見つけることができます。また、集団レベルでのWES(全エクソームシーケンス)データ作成は、現代において増加しています。ホールエクソームシーケンス(WES)は、シーケンスの分野で成功したアプリケーションであり、メンデル表現型やミラー病などの疾患の遺伝子の発見によって証明されています。全エクソームシーケンスは、既知の疾患の原因となる変異の大部分がエクソンで起こるため、全ゲノムシーケンスよりも有用であり、市場での需要が高いため、将来の市場成長を促進すると予想されます。
全ゲノムシーケンスは、疾患診断に関する臨床応用において需要が増加しており、遺伝子内の変異体や突然変異を分離するためのゲノムセグメント内の変異の同定において重要な意味を持っています。さらに、微生物全ゲノムリシーケンシングのような技術は、細菌、ウイルス、または他の微生物の全ゲノムを配列決定し、その配列を既知の参照配列と比較することを含み、したがって疾患診断に役立ちます。このように微生物ゲノム配列決定は、微生物の同定に重要なツールです。さらに、全ゲノムシーケンス技術は、生物内の塩基の順序を特定するために使用され、正確なDNA指紋を作成するために利用されるため、発疹や欠陥を迅速に検出することを可能にする症例の関連付けを支援することができ、したがって、予測期間における市場の成長を強化する感染症診断において重要です。
疾病診断に関連する研究開発や、がん、突然変異疾患、その他の疾病などの治療法改善のための研究開発において、政府プロジェクトにおけるゲノムマッピングの需要が高まっています。さらに、さまざまな国や地域の政府は、研究を進展させ、がんや珍しい疾患、その他の病気を特定し、治療するためのより良い方法を発見するために、何百万ものゲノムの塩基配列を決定しています。例えば、欧州政府は、フランスの「ゲノム医療2025フランス計画」や英国の「10万ゲノムプロジェクト」などのプロジェクトを通じて、この地域の大規模ゲノムデータの改善に取り組んでいます。これらの取り組みにより、NGSの次世代シーケンシング(NGS)インフォマティクス・サービスはこの地域で成長しています。例えば、2022年11月には、ナノポアゲノムシーケンス、AI、クラウドコンピューティングを利用して、スタンフォード医科大学の科学者が患者の全ゲノム配列を5時間以内に決定しました。
2021年11月、イルミナとGenetic Allianceは1億2,000万米ドルの世界イニシアチブ、iHope Genetic Healthプログラムを発表しました。このイニシアチブは、遺伝性疾患の影響を受けるさまざまな患者に全ゲノムシーケンス(WGS)アクセスを世界的に提供することを目的としています。
また2020年には、大手企業のQIAGENがNeuMoDx Molecularを買収し、自動分子検査市場での地位を確保しました。同社は現在、PCR検査技術に基づく中・高スループットのNeuMoDx自動化ソリューションを、最新の製品ポートフォリオの新たな構成要素として組み込んでいます。
所定の市場データを用いて、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。レポートでは以下のカスタマイズが可能です:
Whole Genome Sequencing Market is expected to grow with an impressive CAGR in the forecast period 2024-2028. This can be attributed to factors such as
Whole Genome Sequencing Market (WGS) is a widely used application included in genome, microbial resequencing, and genome sequencing. It is expected to increase significantly with the growing research in genomics. Additionally, a rise in the usage of this technology against COVID-19 in sequencing the data of the COVID-19 virus is expected to drive market growth.
Whole Genome Sequencing Market (WGS) technology can deliver quick results and high-quality data. It can be used to locate, monitor, and address disease outbreaks in a region. WGS is shown to be most useful in research and rarely in therapeutic treatments.
The mapping of novel organisms' genomes, the completion of the genomes of already-known organisms, or the comparison of genomes from other samples all benefit from microbial whole-genome sequencing. To create reliable reference genomes, microbial identification, and other comparative genomic investigations, it is required to sequence the full bacterial, viral, and other microbial genomes.
Increasing technological advancement in NGS instruments and update in technology utilized in Sequencing techniques are adding to further drive the sequencing market growth in the forecast period. Moreover, with its multiplexing feature, next-generation sequencing (NGS) enables microbiology researchers to sequence hundreds of organisms, unlike capillary sequencing or PCR-based methods. NGS-based microbial genome sequencing is time efficient and streamlines the workflow, and does not rely on time-consuming cloning stages like older techniques. Additionally, low-frequency variations and genomic rearrangements that might be overlooked are too expensive to find using current techniques that can be found using NGS (Next Generation Sequencing). Also, population-level WES (whole exome sequencing) data generation has increased in today's time. Whole exome sequencing (WES) is a successful application in the field of sequencing and is proved by the discovery of the genes for the conditions such as Mendelian phenotypes, Miller's disease, and other diseases. Whole exome sequencing is more useful than whole genome sequencing since the majority of known disease-causing mutations take place in exons and are in high demand in the market and thus anticipated to propel the market growth in the future.
Whole genome sequencing has an increased demand in clinical applications regarding disease diagnosis and has significant importance in the identification of a mutation in a genome segment for isolating a variant or mutation in a gene. Moreover, techniques such as Microbial whole-genome resequencing involve the sequencing of the entire genome of a bacteria, virus, or other microbe and comparing the sequence to that of a known reference and thus is helpful in disease diagnosis. This microbial genome sequencing is thus an important tool for microbial identification. Additionally, the whole genome sequencing technique is used for identifying the order of bases in the organism and is thus utilized to produce a precise DNA fingerprint and thus can aid in linking the cases allowing the eruption or defect to be detected quickly and, thus, is significant in infectious disease diagnosis to bolster the market growth in the forecast period.
The rising demand for genome mapping in government projects for the rising research and development related to disease diagnosis and research for improved treatment in cancer, mutated disorders, and other diseases, etc. Furthermore, governments of distinct countries and regions are sequencing millions of genomes to progress research and discover better ways to identify and cure cancer, uncommon disorders, and other ailments. For instance, the European government is undertaking efforts to improve the region's large-scale genomic data with projects such as France's French Plan for Genomic Medicine 2025 and, similarly, the United Kingdom's 100,000 Genomes Project. These initiatives have resulted in the growth of NGS's Next-generation sequencing (NGS) informatics services in the region. For instance, in November 2022, using Nanopore Genome Sequencing, AI, and Cloud Computing, scientists at Stanford Medicine University sequenced a patient's whole genome in under five hours.
In November 2021, Illumina and Genetic Alliance announced a USD 120 million global initiative-the iHope Genetic Health program. This initiative aims to offer Whole Genome Sequencing (WGS) access to various patients impacted by genetic disorders globally.
Also, In 2020, a leading company QIAGEN acquired NeuMoDx Molecular and secured its position in the market in automated molecular testing. The company now includes medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology as a new component of its updated product portfolio.
The whole Genome Sequencing Market is segmented based on the sequencing type, product type, application, end-user, and region. Based on sequencing type, the market is segmented into large whole-genome sequencing and small-genome sequencing. Based on product type, the market is segmented into instruments, kits, and services. Based on application, the market is segmented into diagnostics, drug discovery and development, personalized medicine, and others. Based on end users, the market is further fragmented into hospitals and clinics, pharmaceutical and biotechnology companies, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
GE Healthcare, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics, etc.., are some of the major players operating in the global Whole Genome Sequencing Market.
In this report, Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Whole Genome Sequencing Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: